LILLY FDA Approval NDA 013378

NDA 013378

LILLY

FDA Drug Application

Application #013378

Application Sponsors

NDA 013378LILLY

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORAL500MG0DYMELORACETOHEXAMIDE
002TABLET;ORAL250MG0DYMELORACETOHEXAMIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1964-12-23PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1976-07-21PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1976-09-15PRIORITY
LABELING; LabelingSUPPL15AP1979-01-09
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1979-11-27PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1980-03-21PRIORITY
LABELING; LabelingSUPPL18AP1981-02-23
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1980-10-14PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1983-01-31PRIORITY
LABELING; LabelingSUPPL24AP1985-02-14
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1986-03-18PRIORITY
LABELING; LabelingSUPPL26AP1986-05-02
MANUF (CMC); Manufacturing (CMC)SUPPL27AP1986-09-15PRIORITY
LABELING; LabelingSUPPL28AP1987-01-30
LABELING; LabelingSUPPL29AP1988-12-29
LABELING; LabelingSUPPL30AP1990-11-27
MANUF (CMC); Manufacturing (CMC)SUPPL31AP1998-06-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL32AP1998-10-19PRIORITY

Submissions Property Types

ORIG1Null0
SUPPL13Null0
SUPPL14Null0
SUPPL16Null0
SUPPL17Null0
SUPPL19Null0
SUPPL22Null0
SUPPL25Null0
SUPPL27Null0
SUPPL31Null0
SUPPL32Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 13378
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.